These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34522513)

  • 21. [Clinical presentations of Herpes Zoster Ophthalmicus (diagnosis and therapy)].
    Chernakova GM; Kleshcheva EA; Semenova TB
    Vestn Oftalmol; 2016; 132(5):75-80. PubMed ID: 27911430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes Zoster Ophthalmicus in a Healthy Toddler Fully Immunized Against Varicella-Zoster Virus: A Case Report and Review of Treatment Strategies in Children.
    Keramida P; Antoniadi M; Archimandritou E; Kostaridou S; Koletsi P
    Cureus; 2023 Jan; 15(1):e33352. PubMed ID: 36751223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of delayed cerebral infarction occurring in puerperium preceded by herpes zoster ophthalmicus in late pregnancy].
    Hoshino S; Hayashi A; Yoshizawa T; Tamaoka A; Shoji S
    No To Shinkei; 1999 Jun; 51(6):529-33. PubMed ID: 10423756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital Apex Syndrome Secondary to Herpes Zoster Ophthalmicus.
    Ugurlu S; Atik S; Imre SS
    Neuroophthalmology; 2014; 38(5):260-263. PubMed ID: 27928310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes Zoster Ophthalmicus in an Immunocompetent Child With Concurrent COVID-19 Infection: A Case Report and Literature Review.
    El Belidi H; Cherkaoui LO
    Cureus; 2023 Apr; 15(4):e37020. PubMed ID: 37139034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
    Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
    J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Zoster Ophthalmicus After COVID-19 Vaccination: Chance Occurrence or More?
    Rehman O; Arya SK; Jha UP; Nayyar S; Goel I
    Cornea; 2022 Feb; 41(2):254-256. PubMed ID: 34690265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral antivirals revisited in the treatment of herpes zoster: what do they accomplish?
    Nikkels AF; Piérard GE
    Am J Clin Dermatol; 2002; 3(9):591-8. PubMed ID: 12444801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of varicella zoster virus DNA and viral antigen in human eyes after herpes zoster ophthalmicus.
    Wenkel H; Rummelt V; Fleckenstein B; Naumann GO
    Ophthalmology; 1998 Jul; 105(7):1323-30. PubMed ID: 9663241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated Internal Ophthalmoplegia Secondary to Herpes Zoster Ophthalmicus: A Rare Case Report.
    Top Karti D; Aktert D; Celebisoy N
    Neuroophthalmology; 2020 Apr; 44(2):118-120. PubMed ID: 32395161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preauricular injection of betamethasone depot and acyclovir for the treatment of acute herpes zoster ophthalmicus].
    Arenas-Archila E; Alvizu F; Muñoz-Sarmiento D
    Arch Soc Esp Oftalmol; 2015 Apr; 90(4):195-7. PubMed ID: 25443191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex and herpes zoster eye disease: presentation and management at a city hospital for the underserved in the United States.
    Edell AR; Cohen EJ
    Eye Contact Lens; 2013 Jul; 39(4):311-4. PubMed ID: 23771014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological and Ophthalmological Manifestations of Varicella Zoster Virus.
    Kedar S; Jayagopal LN; Berger JR
    J Neuroophthalmol; 2019 Jun; 39(2):220-231. PubMed ID: 30188405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular complications and loss of vision due to herpes zoster ophthalmicus in patients with HIV infection and a comparison with HIV-negative patients.
    Nithyanandam S; Joseph M; Stephen J
    Int J STD AIDS; 2013 Feb; 24(2):106-9. PubMed ID: 23512510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir.
    Cobo M
    Am J Med; 1988 Aug; 85(2A):90-3. PubMed ID: 3044100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
    Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular manifestation and visual outcomes in herpes zoster ophthalmicus: a prospective study from a tertiary hospital of Eastern India.
    Goswami M; Bhattacharya S; Bandyopadhyay M
    Int J Ophthalmol; 2021; 14(12):1950-1956. PubMed ID: 34926213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report.
    Awaly ZWN
    Clin Exp Vaccine Res; 2023 Jan; 12(1):82-84. PubMed ID: 36844689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine.
    LoBue SA; Tailor P; Carlson SM; Mano F; Giovane RA; Schaefer E; LoBue TD
    Am J Ophthalmol Case Rep; 2019 Dec; 16():100547. PubMed ID: 31497676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.